Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
Researchers at the Sealy Center forVaccine Development at the University of Texas Medical Branch (UTMB) at Galveston have developed a safe vaccine candidate for Chagas disease that is simple to produce and shows a greater than 90 percent protection rate against chronic infection in mice.
A recent study of an experimental therapy that alters cancer patients’ own immune cells to recognize an often deadly form of leukemia has shrunk tumors and sent the cancer into remission in adults.
The Centers for Medicare & Medicaid Services announced its final decision on a coverage policy that will limit patient access to beta-amyloid positron emissiontomography imaging.
The Drug Quality and Security Act (H.R. 3204) that provides uniform, nationwide standards for both pharmacy compounding and drug tracking was enacted into law in November.
The American Autoimmune Related Diseases Association (AARDA) has created a new multimedia public service campaign with tools designed to help patients make informed decisions about newly prescribed therapies and treatments.
A new study shows that more than half of those who write prescriptions today do so electronically.
Collaborating scientists from Nationwide Children’s Hospital, Baylor Institute for Immunology Research and Mount Sinai School of Medicine have identified an important mechanism for stimulating protective immune responses following seasonal influenza vaccinations.
A recent Canadian study showed that the use of influenza vaccine was associated with a lower risk of major adverse cardiovascular events.
A computer model for predicting flu outbreaks weeks in advance has been developed by researchers at Columbia University and the National Center for Atmospheric Research.
A recent study showed that a universal flu vaccine induced levels of anti-flu antibodies 34 times higher in mice and 10 times higher in ferrets compared with a traditional vaccine.
A study conducted by researchers at the Centers for Disease Control and Prevention found that pregnant women can safely receive the meningococcal vaccine Menactra.